Biodexa Pharmaceuticals (BDRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    5.82
    0.21 (3.74%)
    At close: Sep 10, 2025, 3:59 PM
    5.50
    -5.50%
    After-hours: Sep 10, 2025, 07:57 PM EDT

    Biodexa Pharmaceuticals Income Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 381K 699K 578K
    Cost of Revenue
    		 5.44M 4.07M 5.11M 4.65M
    Gross Profit
    		 -5.44M -3.69M -4.41M -4.08M
    Operating Income
    		 -9.2M -8.01M -8.93M -7M
    Interest Income
    		 n/a 83K 29K n/a
    Pretax Income
    		 -5.98M -7.49M -8.49M -6.11M
    Net Income
    		 -5.73M -7.08M -7.66M -5.46M
    Selling & General & Admin
    		 3.79M 4.34M 4.54M 2.95M
    Research & Development
    		 5.44M 4.07M 5.11M 4.65M
    Other Expenses
    		 -5.47M -4.08M n/a n/a
    Operating Expenses
    		 3.76M 4.33M 4.05M 1.99M
    Interest Expense
    		 n/a 41K 53K 44K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 9.2M 8.39M 9.16M 6.64M
    Income Tax Expense
    		 -250K -406K 832K 646K
    Shares Outstanding (Basic)
    		 61.95K 30.00 1.00 1.00
    Shares Outstanding (Diluted)
    		 61.95K 30.00 1.00 1.00
    EPS (Basic)
    		 -1.16M -229K -4.94M -3.52M
    EPS (Diluted)
    		 -1.16M -229K -4.94M -3.52M
    EBITDA
    		 -9.08M -7.16M -7.39M -5.66M
    EBIT
    		 -9.2M -7.44M -8.44M -6.06M
    Depreciation & Amortization
    		 117K 283K 343K 403K

    Add to Watchlist